CAS 922175-70-0

Formula: C34H52N10O12

InChI: InChI=1S/C34H52N10O12/c35-15-22-25(48)26(49)27(50)28(56-22)33(55)38-11-5-4-9-19-30(52)42-18(10-6-12-39-34(36)37)29(51)40-16-23(45)41-21(14-24(46)47)32(54)44-20(31(53)43-19)13-17-7-2-1-3-8-17/h1-3,7-8,18-22,25-28,48-50H,4-6,9-16,35H2,(H,38,55)(H,40,51)(H,41,45)(H,42,52)(H,43,53)(H,44,54)(H,46,47)(H4,36,37,39)

InChI key: GUPUFVWCDYSPBQ-UHFFFAOYSA-N

SMILES: C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCCNC(=O)C2C(C(C(C(O2)CN)O)O)O)CC3=CC=CC=C3)CC(=O)O

Galacto-RGD

CAS: 922175-70-0

Radiolabeled analogs of Galacto-RGD are useful for studying expression of α₅β₃ integrin in tumor cells

Formula: C₃₄H₅₂N₁₀O₁₂

Purezza: 97.3%

Peso molecolare: 792.85

Ref: 01-4055350

Galactosyl-Cyclo(Arg-Gly-Asp-D-Phe-Lys)

CAS: 922175-70-0

Galactosyl-Cyclo(Arg-Gly-Asp-D-Phe-Lys) is a monoclonal antibody that binds to the integrin receptor, which is involved in the proliferation and migration of cells. It has been shown to be an effective treatment for prostate cancer cells in vitro. Galactosyl-Cyclo(Arg-Gly-Asp-D-Phe-Lys) also shows potential as a biomarker for atherosclerotic lesions. The drug has been shown to have pharmacokinetic properties in humans and can inhibit epidermal growth factor (EGF) activity.

Formula: C₃₄H₅₂N₁₀O₁₂

Purezza: Min. 95%

Peso molecolare: 792.85 g/mol

Ref: 3D-RGD-3736-PI

Galacto-RGD trifluoroacetate salt

CAS: 922175-70-0

Please enquire for more information about Galacto-RGD trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formula: C₃₄H₅₂N₁₀O₁₂

Purezza: Min. 95%

Colore e forma: Powder

Peso molecolare: 792.84 g/mol

Ref: 3D-FG109867